Ftse Mib
33.553,85
-0,45%
DAX
18.185,99
0,13%
S&P 500
5.469,30
0,39%
NASDAQ
17.717,65
1,26%
Bitcoin
61.374,31
-0,71%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Immunome Inc (IMNM) Immunome Inc (IMNM) Notizie

IMNM

Immunome (IMNM)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:IMNM
DataOraFonteTitoloSimboloCompagnia
19/06/202403:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMNMImmunome Inc
19/06/202403:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IMNMImmunome Inc
13/06/202422:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMNMImmunome Inc
20/05/202414:00Business WireImmunome Announces Completion of Purchase of Assets from AtrecaNASDAQ:IMNMImmunome Inc
17/05/202414:00Business WireImmunome Announces Promotion of Max Rosett to Chief Financial OfficerNASDAQ:IMNMImmunome Inc
14/05/202414:48Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IMNMImmunome Inc
14/05/202414:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IMNMImmunome Inc
14/05/202414:00Business WireImmunome Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:IMNMImmunome Inc
08/05/202414:00Business WireImmunome to Present at 2024 Bank of America Healthcare ConferenceNASDAQ:IMNMImmunome Inc
02/05/202414:00Business WireImmunome Appoints Kinney Horn as Chief Business OfficerNASDAQ:IMNMImmunome Inc
25/04/202414:26Business WireImmunome Appoints Sandra M. Swain to Board of DirectorsNASDAQ:IMNMImmunome Inc
05/04/202414:00Business WireImmunome to Present Preclinical Data for IM-3050, Its Lead Radioligand Therapy Candidate, at 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:IMNMImmunome Inc
28/03/202421:02Business WireImmunome Reports Full Year 2023 Financial Results and Provides Update on Recently Acquired AssetsNASDAQ:IMNMImmunome Inc
26/03/202413:00Business WireImmunome Completes Acquisition of AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From AyalaNASDAQ:IMNMImmunome Inc
07/03/202414:00Business WireImmunome to Participate in the Leerink Partners Global Biopharma ConferenceNASDAQ:IMNMImmunome Inc
01/03/202414:00Business WireImmunome to Participate in the TD Cowen 44th Annual Healthcare ConferenceNASDAQ:IMNMImmunome Inc
20/02/202414:15Business WireImmunome Recognizes Ayala Pharmaceuticals’ Announced Completion of Enrollment in Phase 3 RINGSIDE Study Evaluating AL102 in Desmoid TumorsNASDAQ:IMNMImmunome Inc
16/02/202422:05Business WireImmunome Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:IMNMImmunome Inc
14/02/202404:38Business WireImmunome Announces Pricing of Public Offering of Common StockNASDAQ:IMNMImmunome Inc
13/02/202422:05Business WireImmunome Announces Proposed Public Offering of Common StockNASDAQ:IMNMImmunome Inc
12/02/202420:10Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IMNMImmunome Inc
05/02/202414:00Business WireImmunome to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:IMNMImmunome Inc
02/02/202422:04Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:IMNMImmunome Inc
08/01/202413:00Business WireImmunome Exclusively Licenses Zentalis ROR1 Antibody-Drug Conjugate and Proprietary Technology PlatformNASDAQ:IMNMImmunome Inc
04/01/202414:00Business WireImmunome Appoints Phil Roberts as Chief Technical OfficerNASDAQ:IMNMImmunome Inc
03/01/202414:00Business WireImmunome to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:IMNMImmunome Inc
02/01/202414:00Business WireImmunome Appoints Carol A. Schafer to Board of DirectorsNASDAQ:IMNMImmunome Inc
26/12/202314:30GlobeNewswire Inc.Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to ImmunomeNASDAQ:IMNMImmunome Inc
26/12/202314:30Business WireImmunome to Acquire Antibody-Related Assets and Materials from AtrecaNASDAQ:IMNMImmunome Inc
28/11/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IMNMImmunome Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:IMNM

La tua Cronologia

TSX
CINT
CIBC International Equit...
ASX
W2VO
Way 2 Vat
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network